Diabetes, Obesity and Metabolism

1. Diabetes Obes Metab15 Dec 2025

   Literature‐informed ensemble machine learning for three‐year diabetic kidney disease risk prediction in type 2 diabetes: Development, validation, and deployment of the PSMMC NephraRisk model

   Diagnostic or prognostic studyComplications

2. Diabetes Obes Metab15 Dec 2025

   Taxonomic and functional shifts in the microbiome of severely obese, prediabetic patients: Ketogenic diet versus energy‐matched standard diet

   Randomized controlled trialObesity

3. Diabetes Obes Metab15 Dec 2025

   Insulin therapy DE ‐ intensificAtion with iGlarLixi : A phase 4, open‐label, parallel‐group randomised controlled trial

   Randomized controlled trialT2D & other

4. Diabetes Obes Metab15 Dec 2025

   Associations between steatotic liver disease subtypes and incident diabetes in young Korean adults: A nationwide cohort study

   Cohort studyLipids & liver

5. Diabetes Obes Metab15 Dec 2025

   Injection‐site and dermatologic reactions associated with glucagon‐like peptide‐1 receptor agonists: Insights from meta‐analysis of randomised controlled trials and real‐world evidence

   Meta-analysisT2D & other

6. Diabetes Obes Metab15 Dec 2025

   Oxytocin levels do not change around a meal and correlate with reward‐driven caloric consumption in adults with obesity

   Mechanistic studyObesity

7. Diabetes Obes Metab12 Dec 2025

   Disentangling the relationship between glucose, insulin and brain health: A UK Biobank study

   Research article

8. Diabetes Obes Metab12 Dec 2025

   Efficacy and hypoglycaemia outcomes of once‐weekly insulin icodec versus once‐daily basal insulin comparators across baseline HbA1c , BMI and duration of type 2 diabetes subgroups: A post hoc analysis of ONWARDS 1–5

   Secondary analysisT2D & other

9. Diabetes Obes Metab12 Dec 2025

   Impact of stepwise diabetes technology advances in older adults with type 1 diabetes: A systematic review and meta‐analysis of randomised trials

   Meta-analysisTechnology

10. Diabetes Obes Metab12 Dec 2025

    Use of sodium‐glucose cotransporter‐2 inhibitors among older adults with type 2 diabetes mellitus in British Columbia

    Cohort studyT2D & other

11. Diabetes Obes Metab10 Dec 2025

    Explainable machine learning‐driven predictive modelling of incident cognitive impairment in individuals with early‐stage cardiovascular–kidney–metabolic syndrome: Insights from a longitudinal CHARLS cohort study

    Cohort study

12. Diabetes Obes Metab10 Dec 2025

    Clinical implications of intentional weight loss in people living with type 2 diabetes: A real‐world database study

    Cohort studyT2D & other

13. Diabetes Obes Metab9 Dec 2025

    CGM ‐derived average glucose is more strongly associated with microvascular complications than HbA1c in type 1 diabetes

    Cross-sectional studyT1D

14. Diabetes Obes Metab9 Dec 2025

    GLP ‐1 receptor agonists for treating obesity without diabetes: A systematic review and meta‐analysis of economic evaluations

    Meta-analysisObesity

15. Diabetes Obes Metab9 Dec 2025

    Immunogenicity, efficacy and safety of a biosimilar insulin glulisine compared with originator in adults with type 1 diabetes mellitus: A phase III randomised clinical trial

    Randomized controlled trialT1D

16. Diabetes Obes Metab9 Dec 2025

    Income‐related inequities in the progression from gestational to type 2 diabetes: Findings from Taiwan's maternal and child health database

    Cohort studyDiabetes in pregnancy

17. Diabetes Obes Metab9 Dec 2025

    Meta‐analysis of clinically available pharmacotherapy of biopsy confirmed metabolic dysfunction associated steatohepatitis ( MASH )

    Meta-analysisLipids & liver

18. Diabetes Obes Metab8 Dec 2025

    A novel glucose beta‐hydroxybutyrate combination improves hypoglycaemia recovery and patient‐reported outcomes in type 1 diabetes

    Randomized controlled trialT1D

19. Diabetes Obes Metab5 Dec 2025

    Unintentional periconceptional exposure to glucagon‐like peptide‐1 receptor agonists and adverse pregnancy outcomes: A nationwide cohort study in Taiwan

    Cohort studyDiabetes in pregnancy

20. Diabetes Obes Metab5 Dec 2025

    Challenging the obesity paradox in cognitive function: Weight‐adjusted waist index as an obesity indicator in older adults

    Cohort studyObesity

21. Diabetes Obes Metab5 Dec 2025

    The impact of telehealth‐delivered Medical Nutrition Therapy on diabetes outcomes in rural general practice: A secondary analysis of the Healthy Rural Hearts randomised controlled trial

    Secondary analysisT2D & other

22. Diabetes Obes Metab4 Dec 2025

    Safety and effectiveness of tirzepatide during Ramadan fasting: Real‐world evidence from patients with type 2 diabetes in Bangladesh

    Cohort studyT2D & other

23. Diabetes Obes Metab4 Dec 2025

    Relation of the stress hyperglycaemia ratio to residual risk in anticoagulated patients with atrial fibrillation: A report from the prospective Murcia AF Project III cohort

    Cohort study

24. Diabetes Obes Metab4 Dec 2025

    Low immunogenicity of insulin efsitora alfa in participants with type 1 and type 2 diabetes mellitus

    Meta-analysisT2D & other

25. Diabetes Obes Metab3 Dec 2025

    Evaluating the use of virtual reality for weight management: A systematic review and meta‐analysis

    Meta-analysisObesity

26. Diabetes Obes Metab2 Dec 2025

    Severity of complications is associated with impaired health‐related quality of life in people with type 1 diabetes

    Cross-sectional studyT1D

27. Diabetes Obes Metab1 Dec 2025

    Efficacy and safety of liraglutide in non‐alcoholic fatty liver disease with or without type 2 diabetes: A systematic review and meta‐analysis

    Meta-analysisLipids & liver

28. Diabetes Obes Metab1 Dec 2025

    Association of cumulative exposure to cholesterol, high‐density lipoprotein, and glucose index with the risk of cardiovascular disease and all‐cause mortality: A longitudinal cohort study

    Cohort studyLipids & liver

29. Diabetes Obes Metab1 Dec 2025

    Obesity mortality on the rise: A 54‐year US perspective

    Cohort studyObesity

30. Diabetes Obes Metab1 Dec 2025

    Annual prevalence of the body mass index documentation in the UK primary care: A cross‐sectional study using IQVIA medical research data

    Cross-sectional studyObesity

31. Diabetes Obes Metab28 Nov 2025

    SGLT2 inhibitor or metformin as standard treatment in early‐stage type 2 diabetes? Baseline data in SMARTEST , a novel, decentralised, register‐based randomised trial on prevention of diabetic complications

    Randomized controlled trialT2D & other

32. Diabetes Obes Metab28 Nov 2025

    Therapeutic equivalence and switching between biosimilar and reference insulins: A systematic review and meta‐analysis of randomised controlled trials

    Meta-analysisT2D & other

33. Diabetes Obes Metab27 Nov 2025

    Comparative effectiveness of sodium‐glucose cotransporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists for incident dementia: A retrospective multicohort study

    Cohort studyT2D & other

34. Diabetes Obes Metab27 Nov 2025

    Cost‐effectiveness of continuous glucose monitoring in Chinese adults with uncontrolled type 2 diabetes: A modelling study stratified by baseline HbA 1c

    Research articleTechnology

35. Diabetes Obes Metab27 Nov 2025

    PIONEER REAL Saudi Arabia: A multicentre, prospective, real‐world study of once‐daily oral semaglutide use in adults with type 2 diabetes in Saudi Arabia

    Cohort studyT2D & other

36. Diabetes Obes Metab26 Nov 2025

    Safety and efficacy of the therapy with CD4 + CD25highCD127 ‐T regulatory cells: When paediatric patient becomes adult

    Secondary analysisT1D

37. Diabetes Obes Metab25 Nov 2025

    Obicetrapib for dyslipidemia with or without cardiovascular risk: A GRADE ‐assessed meta‐analysis of randomized trials with trial sequential evidence

    Meta-analysisLipids & liver

38. Diabetes Obes Metab25 Nov 2025

    Sensory network dysregulation in type 2 diabetes: Linking olfactory, visual, and cognitive function

    Cross-sectional studyT2D & other

39. Diabetes Obes Metab25 Nov 2025

    Assessment of thyroid cancer risk associated with glucagon‐like peptide 1 receptor agonist use

    Meta-analysisT2D & other

40. Diabetes Obes Metab25 Nov 2025

    Association of baseline characteristics with clinical outcomes of tirzepatide treatment in Japanese patients with obesity disease: A subgroup analysis of the SURMOUNT ‐J trial

    Secondary analysisObesity

All 2,200 Briefs in ExploreShowing Briefs 721–760 of 2,200, newest first